Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 30;16(6):681.
doi: 10.3390/genes16060681.

Pre- and Postoperative Cell-Free Fetal DNA Analyses for Detecting Aneuploidy in Early Pregnancy Loss: Single-Center Prospective Cohort Study

Takeshi Nagao  1 , Yuki Ito  1 , Akari Moriyama  1 , Chika Tei  1 , Aikou Okamoto  1 , Osamu Samura  1
Affiliations

Pre- and Postoperative Cell-Free Fetal DNA Analyses for Detecting Aneuploidy in Early Pregnancy Loss: Single-Center Prospective Cohort Study

Takeshi Nagao et al. Genes (Basel). .

Abstract

Background/Objective: Early pregnancy loss is often caused by chromosomal abnormalities, necessitating accurate diagnostic tools. While product of conception (POC) chromosomal testing is commonly used, it can be limited by culture failure or an inability to obtain fetal tissue due to spontaneous expulsion. Cell-free fetal DNA (cff DNA) analysis provides a non-invasive alternative; however, its effectiveness in early pregnancy loss, particularly in cases where fetal components are still minimal, has not been fully established. The objective of this study was to evaluate the accuracy of pre- and postoperative cff DNA analysis for detecting fetal aneuploidy by comparing the results to those of POC chromosomal testing. Methods: In this single-center prospective cohort study, 50 women undergoing manual vacuum aspiration for pregnancy loss before 12 weeks of gestation were enrolled (February 2022-December 2024). Cff DNA analysis was performed on maternal blood samples collected pre- and postoperatively. The primary outcome was concordance between the cff DNA and POC results. Sensitivity, specificity, and factors affecting concordance were also assessed. Results: Eight participants were excluded due to unsuccessful POC culture (n = 3), suspected maternal tissue contamination in the POC sample (n = 1), mosaicism (n = 3), or triploidy (n = 1), resulting in 42 evaluable cases. Preoperative cff DNA analysis showed 88.1% concordance with POC (sensitivity 86.4% and specificity 90.0%). Postoperative analysis showed 78.6% concordance (sensitivity 72.7% and specificity 85.0%). Conclusions: The Cff DNA analysis of preoperative and postoperative maternal blood samples showed generally good concordance with conventional POC chromosomal testing in detecting fetal aneuploidy in early pregnancy loss.

Keywords: aneuploidy; cell-free fetal DNA; early pregnancy loss; fetal fraction; miscarriage; next-generation sequencing; non-invasive prenatal testing; product of conception testing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The participant selection flowchart. Women who experienced pregnancy loss before 12 weeks of gestation and were scheduled for manual vacuum aspiration are enrolled. Maternal blood samples are collected preoperatively and postoperatively for cff DNA analysis, and the results are evaluated for concordance with the POC chromosomal testing results.
See this image and copyright information in PMC

References

    1. Magnus M.C., Wilcox A.J., Morken N.H., Weinberg C.R., Håberg S.E. Role of maternal age and pregnancy history in risk of miscarriage: Prospective register based study. BMJ. 2019;364:l869. doi: 10.1136/bmj.l869. - DOI - PMC - PubMed
    1. Essers R., Lebedev I.N., Kurg A., Fonova E.A., Stevens S.J.C., Koeck R.M., von Rango U., Brandts L., Deligiannis S.P., Nikitina T.V. Prevalence of chromosomal alterations in first-trimester spontaneous pregnancy loss. Nat. Med. 2023;29:3233–3242. doi: 10.1038/s41591-023-02645-5. - DOI - PMC - PubMed
    1. Practice Committee of the American Society for Reproductive Medicine Evaluation and treatment of recurrent pregnancy loss: A committee opinion. Fertil. Steril. 2012;98:1103–1111. doi: 10.1016/j.fertnstert.2012.06.048. - DOI - PubMed
    1. Fritz B., Hallermann C., Olert J., Fuchs B., Bruns M., Aslan M., Schmidt S., Coerdt W., Müntefering H., Rehder H. Cytogenetic analyses of culture failures by comparative genomic hybridisation (CGH)-Re-evaluation of chromosome aberration rates in early spontaneous abortions. Eur. J. Hum. Genet. EJHG. 2001;9:539–547. doi: 10.1038/sj.ejhg.5200669. - DOI - PubMed
    1. Samura O. Update on noninvasive prenatal testing: A review based on current worldwide research. J. Obstet. Gynaecol. Res. 2020;46:1246–1254. doi: 10.1111/jog.14268. - DOI - PubMed

Substances